Kendle has promoted Stephen Cutler to president and CEO. Cutler succeeds Candace Kendle who continues as chairman. Jamie Macdonald has been hired to fill the positions of senior vice president (SVP) and chief operating officer vacated by promotion of Cutler.
Also, Christopher Bergen is to step down as EVP and chief administrative officer but will remain on the board of directors at Kendle. All the changes are effective from May 1.
David Grange is to retire as CEO and member of the board of PPD in May. Grange joined the PPD board as an independent director in 2003 before becoming CEO in 2009. PPD will initiate an internal and external search for successor. Grange will consult PPD throughout 2011.
INC Research has bolstered its Indian operations with two appointments. Shabbir Rangwala, formerly of Eli Lilly, has joined as executive director, global services and site head, and Sunil Garg, who last worked at SIRO Clinpharm, is the new senior manager, clinical operations.
Sue Robinson has been named as director of patient recruitment at Premier Research. Robinson has previously worked at Kendle and Bios Clinical Research Organisation.
NextPharma has appointed Brigitte Genard as quality director at its site in Braine-l’Alleud, Belgium. Genard has vaccine and biologics production experience from working at GlaxoSmithKline and UCB.
Brandon Griffin has joined Advantar Labs as VP of sales and marketing. Griffin has previously worked at RohnerChem, Analytical Bio-Chemistry Laboratories and Irvine Pharmaceutical Services.
Pharm-Olam has named Connie Andrews as VP of global services. Andrews has worked at a number of biopharm and service providers, including Pfizer, MedImmune, Quintiles, ClinOps and Omnicare.
Sean McCrossen has been added to the team of consultants at Pharmaceutical Development Services (PDS). McCrossen has been hired to add chemistry and manufacturing control (CMC) regulatory dossier rectification expertise to PDS.
Clinilabs has appointed Stephen Murray as chief medical officer. Murray worked at Janssen Pharmaceuticals and Pfizer before serving as chief medical officer at several biotech companies.